Published in Ann Oncol on June 09, 2006
Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res (2008) 2.94
Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study. Support Care Cancer (2008) 1.37
Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer. Nat Rev Clin Oncol (2009) 1.34
Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol (2011) 1.26
Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now? Support Care Cancer (2010) 1.11
Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy. Support Care Cancer (2010) 1.07
Cost effectiveness of TAC versus FAC in adjuvant treatment of node-positive breast cancer. Curr Oncol (2010) 0.96
A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer (2010) 0.95
Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer model. PLoS One (2013) 0.94
Delayed emotional recovery after taxane-based chemotherapy. Cancer (2008) 0.93
Canadian supportive care recommendations for the management of neutropenia in patients with cancer. Curr Oncol (2008) 0.93
Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy. Support Care Cancer (2015) 0.92
Primary G-CSF prophylaxis for adjuvant TC or FEC-D chemotherapy outside of clinical trial settings: a systematic review and meta-analysis. Support Care Cancer (2012) 0.92
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial. Breast Cancer Res (2011) 0.91
Heath-related quality of life in Spanish breast cancer patients: a systematic review. Health Qual Life Outcomes (2011) 0.86
The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma. BMC Cancer (2010) 0.85
Use of pegfilgrastim primary prophylaxis and risk of infection, by chemotherapy cycle and regimen, among patients with breast cancer or non-Hodgkin's lymphoma. Support Care Cancer (2014) 0.84
Presentation and management of docetaxel-related adverse effects in patients with breast cancer. Cancer Manag Res (2014) 0.83
Improving symptom communication through personal digital assistants: the CHAT (Communicating Health Assisted by Technology) project. J Natl Cancer Inst Monogr (2013) 0.81
Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial. Support Care Cancer (2015) 0.79
Primary or secondary G-CSF prophylaxis to support TAC chemotherapy in breast cancer? Ann Oncol (2006) 0.79
A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09. Support Care Cancer (2015) 0.79
Refining docetaxel-containing therapy for gastric cancer. Gastrointest Cancer Res (2011) 0.78
Filling in the gaps: reporting of concurrent supportive care therapies in breast cancer chemotherapy trials. Support Care Cancer (2011) 0.77
Chemotherapy in early breast cancer: when, how and which one? Breast Care (Basel) (2014) 0.77
Evaluation of host quality of life and immune function in breast cancer patients treated with combination of adjuvant chemotherapy and oral administration of Lentinula edodes mycelia extract. Onco Targets Ther (2013) 0.77
Myelo-enhancement by astragalus membranaceus in male albino rats with chemotherapy myelo-suppression. Histological and immunohistochemical study. Int J Stem Cells (2014) 0.76
The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools. Breast Care (Basel) (2009) 0.76
Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer. Clin Transl Oncol (2014) 0.76
The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort study. Springerplus (2015) 0.75
Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancer. Mol Clin Oncol (2015) 0.75
Weekly taxane-anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial. Chin J Cancer (2017) 0.75
Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer. Breast Care (Basel) (2012) 0.75
Taxane Combination Chemotherapy in Breast Cancer: Experience from a Tertiary Cancer Centre in India. Indian J Med Paediatr Oncol (2017) 0.75
Prognostic Value of Chemotherapy-Induced Neutropenia at the First Cycle in Invasive Breast Cancer. Medicine (Baltimore) (2016) 0.75
Clinical equivalence with G-CSF biosimilars: methodologic approach in a (neo)adjuvant setting in non-metastatic breast cancer. Support Care Cancer (2017) 0.75
Lentinula edodes mycelia extract plus adjuvant chemotherapy for breast cancer patients: Results of a randomized study on host quality of life and immune function improvement. Mol Clin Oncol (2017) 0.75
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Invest (1994) 4.39
Regulation of mammalian circadian behavior by non-rod, non-cone, ocular photoreceptors. Science (1999) 3.96
Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status. Clin Chim Acta (1997) 3.93
Regulation of the mammalian pineal by non-rod, non-cone, ocular photoreceptors. Science (1999) 3.41
Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM). Ann Oncol (2010) 3.00
Validity, reliability and ease of use in the field of five rapid tests for the diagnosis of Plasmodium falciparum malaria in Uganda. Trans R Soc Trop Med Hyg (2002) 2.66
[The Spanish version of EuroQol: a description and its applications. European Quality of Life scale]. Med Clin (Barc) (1999) 2.58
Vertical strabismus after cataract surgery. Ophthalmology (1996) 2.56
How malleable is the eukaryotic genome? Extreme rate of chromosomal rearrangement in the genus Drosophila. Genome Res (2001) 2.48
Appetite control: methodological aspects of the evaluation of foods. Obes Rev (2010) 2.29
Spinal anaesthesia with 0.5% isobaric bupivacaine in patients with diabetes mellitus: the influence of CSF composition on sensory and motor block. Eur J Anaesthesiol (2008) 2.15
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12
Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively. Eur J Surg Oncol (2013) 2.09
[Validity of the Spanish version of the Pediatric Quality of Life Questionnaire for evaluating quality of life in asthmatic children]. Med Clin (Barc) (2001) 2.09
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation. Eur Respir J (2010) 2.08
Molecular characterization of two natural hotspots in the Drosophila buzzatii genome induced by transposon insertions. Genome Res (2001) 1.98
A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making (2001) 1.94
[Cervical cancer screening. False negative smears]. Rev Med Suisse Romande (1997) 1.94
Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer. J Clin Oncol (1999) 1.88
The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat Med (1996) 1.86
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer. Ann Oncol (2004) 1.85
Stromal disrupting effects of nab-paclitaxel in pancreatic cancer. Br J Cancer (2013) 1.85
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.84
Generation of a widespread Drosophila inversion by a transposable element. Science (1999) 1.81
Recombination and gene flux caused by gene conversion and crossing over in inversion heterokaryotypes. Genetics (1997) 1.79
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (1999) 1.74
Gas-liquid chromatography of cellular fatty acids for identification of staphylococci. J Clin Microbiol (1994) 1.71
Intracytoplasmic sperm injection as a routine indication in low responder patients. Hum Reprod (1998) 1.68
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial. Ann Oncol (2008) 1.66
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess (2013) 1.66
Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS) Ann Oncol (1998) 1.60
Malignant proliferating trichilemmal tumours: an histopathological and immunohistochemical study of three cases with DNA ploidy and morphometric evaluation. Histopathology (1998) 1.59
Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells. Infect Immun (2001) 1.59
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. Ann Oncol (2006) 1.58
Electrostatic force microscopy on oriented graphite surfaces: coexistence of insulating and conducting behaviors. Phys Rev Lett (2006) 1.58
Clinical activity of chronic oral etoposide in previously treated metastatic breast cancer. J Clin Oncol (1994) 1.56
Two-dimensional echocardiographic features of echinococcosis of the heart and great blood vessels. Clinical and surgical implications. Circulation (1988) 1.56
A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth (2011) 1.55
Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant (2011) 1.54
Pseudoaneurysm of the superficial temporal artery treated by embolization: report of a case. J Oral Maxillofac Surg (2000) 1.53
Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC. Oncogene (2010) 1.50
Effects of strength training on muscle power and serum hormones in middle-aged and older men. J Appl Physiol (1985) (2001) 1.50
Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. Br J Cancer (2012) 1.48
[Clinical practice guideline based on the evidence for the management of sedoanalgesia in the critically ill adult patient]. Med Intensiva (2007) 1.48
Monosynaptic GABAergic signaling from dentate to CA3 with a pharmacological and physiological profile typical of mossy fiber synapses. Neuron (2001) 1.48
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Ann Oncol (2003) 1.48
Role of glutathione S-transferases in melanoma susceptibility: association with GSTP1 rs1695 polymorphism. Br J Dermatol (2012) 1.47
Effect of inversion polymorphism on the neutral nucleotide variability of linked chromosomal regions in Drosophila. Genetics (2000) 1.46
Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat (1999) 1.42
The "El Alamo" project (1990-1997): two consecutive hospital-based studies of breast cancer outcomes in Spain. Clin Transl Oncol (2006) 1.41
High-fat versus high-carbohydrate enteral formulae: effect on blood glucose, C-peptide, and ketones in patients with type 2 diabetes treated with insulin or sulfonylurea. Nutrition (1999) 1.40
Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma. Cancer (1998) 1.40
Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology. Clin Transl Oncol (2014) 1.40
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
[Evaluation of two methods to avoid the nephropathy associated with radiologic contrast]. Medicina (B Aires) (1999) 1.40
[Variable response to the biological inhibition of platelets by abciximab in patients subjected to percutaneous coronary angioplasty]. Rev Esp Cardiol (2001) 1.40
Differential intraocular pressure in restrictive strabismus. Am J Ophthalmol (1991) 1.40
[Paradoxical myelosuppression with granulocyte-stimulating factor (G-CSF) and simultaneous administration chemotherapy]. Med Clin (Barc) (1993) 1.39
[Effects of postoperative autotransfusion in prosthetic surgery of the hip with the ConstaVac device]. Ann Fr Anesth Reanim (1993) 1.39
Treatment of advanced colorectal cancer with recombinant interferon alpha and fluorouracil: activity in liver metastasis. Cancer Invest (1992) 1.39
[Treatment of prostate cancer according to life expectancy, comorbidity and clinical practice guidelines]. An Sist Sanit Navar (2015) 1.39
[Cost-benefit of the Schilling test using cobalt-57]. Rev Invest Clin (1992) 1.38
Use of buccal fat pad to repair intraoral defects: review of 30 cases. Br J Oral Maxillofac Surg (1997) 1.37
[The 2013 Seville Consensus Document on alternatives to allogenic blood transfusion. An update on the Seville Document]. Rev Esp Anestesiol Reanim (2013) 1.37
Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth (2008) 1.36
Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect Immun (1995) 1.36
Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res (1999) 1.33
Cellobiose oxidase from Phanerochaete chrysosporium can be cleaved by papain into two domains. Eur J Biochem (1991) 1.33
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Ann Oncol (2011) 1.33
Effect of Lepidium meyenii (maca) roots on spermatogenesis of male rats. Asian J Androl (2001) 1.30
Nurses as providers of emotional support to patients with MDR-TB. Int Nurs Rev (2006) 1.30
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer. Clin Cancer Res (2000) 1.30
Comparison of dose calculation algorithms in phantoms with lung equivalent heterogeneities under conditions of lateral electronic disequilibrium. Med Phys (2004) 1.28
Gas-liquid chromatographic analysis of cellular fatty acids for identification of gram-negative anaerobic bacilli. J Clin Microbiol (1991) 1.27
The 1,4-beta-D-glucan cellobiohydrolases from Phanerochaete chrysosporium. I. A system of synergistically acting enzymes homologous to Trichoderma reesei. J Biotechnol (1991) 1.27
Genetic diversity within and between European pig breeds using microsatellite markers. Anim Genet (2006) 1.26
Inhibition of active chloride transport by piretanide. Nature (1978) 1.24
Action of bromazepam on sleep of children with night terrors. I. Sleep organization and heart rate. Pharmatherapeutica (1982) 1.24
Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins? Hum Reprod (1989) 1.24
Functional association between Arf and RalA in active phospholipase D complex. Proc Natl Acad Sci U S A (1998) 1.24
A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study. Breast Cancer Res Treat (2012) 1.22
Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein. J Virol (2001) 1.22
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial. Ann Oncol (2005) 1.21
Mycobacterium tuberculosis DNA detection in soluble fraction of urine from pulmonary tuberculosis patients. Int J Tuberc Lung Dis (2008) 1.20
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Ann Oncol (2010) 1.20